[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Dibigatran Market Data Survey Report 2013-2025

April 2019 | 67 pages | ID: GF0F9783ED8EN
HeyReport

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

The global Dibigatran market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:

Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type

Key manufacturers are included based on company profile, sales data and product specifications etc.:
  • Pfizer, Inc. (US)
  • Bayer Healthcare AG (Germany)
  • GlaxoSmithKline Plc. (UK)
  • Boehringer Ingelheim (Germany)
  • Sanofi S.A. (France)
  • Abbott India Limited (India)
  • Aspen Holdings (South Africa)
  • Bristol-Myers Squibb Company (US)
  • Eisai Inc. (US)
  • Mitsubishi Tanabe Pharma Corporation (Japan)
  • Teva Pharmaceutical Industries Ltd. (Israel)
Major applications as follows:
  • stroke
  • deep vein thrombosis
  • pulmonary embolism
  • systemic embolism
Major Type as follows:
  • Pradaxa
  • Pradax
  • Prazaxa
Regional market size, production data and export & import:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.4 Scope of Type
  1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 Pfizer, Inc. (US)
  3.1.1 Company Information
  3.1.2 Product & Services
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.1.4 Recent Development
3.2 Bayer Healthcare AG (Germany)
  3.2.1 Company Information
  3.2.2 Product & Services
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.2.4 Recent Development
3.3 GlaxoSmithKline Plc. (UK)
  3.3.1 Company Information
  3.3.2 Product & Services
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.3.4 Recent Development
3.4 Boehringer Ingelheim (Germany)
  3.4.1 Company Information
  3.4.2 Product & Services
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.4.4 Recent Development
3.5 Sanofi S.A. (France)
  3.5.1 Company Information
  3.5.2 Product & Services
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.5.4 Recent Development
3.6 Abbott India Limited (India)
  3.6.1 Company Information
  3.6.2 Product & Services
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.6.4 Recent Development
3.7 Aspen Holdings (South Africa)
  3.7.1 Company Information
  3.7.2 Product & Services
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.7.4 Recent Development
3.8 Bristol-Myers Squibb Company (US)
  3.8.1 Company Information
  3.8.2 Product & Services
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.8.4 Recent Development
3.9 Eisai Inc. (US)
  3.9.1 Company Information
  3.9.2 Product & Services
  3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.9.4 Recent Development
3.10 Mitsubishi Tanabe Pharma Corporation (Japan)
  3.10.1 Company Information
  3.10.2 Product & Services
  3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Teva Pharmaceutical Industries Ltd. (Israel)
  3.11.1 Company Information
  3.11.2 Product & Services
  3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 MAJOR APPLICATION

4.1 stroke
  4.1.1 Overview
  4.1.2 stroke Market Size and Forecast
4.2 deep vein thrombosis
  4.2.1 Overview
  4.2.2 deep vein thrombosis Market Size and Forecast
4.3 pulmonary embolism
  4.3.1 Overview
  4.3.2 pulmonary embolism Market Size and Forecast
4.4 systemic embolism
  4.4.1 Overview
  4.4.2 systemic embolism Market Size and Forecast

5 MARKET BY TYPE BY PRADAXA

5.1 Pradaxa
  5.1.1 Overview
  5.1.2 Pradaxa Market Size and Forecast
5.2 Pradax
  5.2.1 Overview
  5.2.2 Pradax Market Size and Forecast
5.3 Prazaxa
  5.3.1 Overview
  5.3.2 Prazaxa Market Size and Forecast

6 PRICE OVERVIEW

6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type

7 CONCLUSION

LIST OF TABLES

Tab Regional Production 2013-2018 (Million USD)
Tab Regional Production 2013-2018 (Volume)
Tab Regional Demand and CAGR 2013-2018 (Million USD)
Tab Regional Demand and CAGR 2013-2018 (Volume)
Tab Regional Demand Forecast and CAGR 2019-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2019-2025 (Volume)
Tab Regional Export 2013-2018 (Million USD)
Tab Regional Export 2013-2018 (Volume)
Tab Regional Import 2013-2018 (Million USD)
Tab Regional Import 2013-2018 (Volume)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Pfizer, Inc. (US)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Bayer Healthcare AG (Germany)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of GlaxoSmithKline Plc. (UK)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Boehringer Ingelheim (Germany)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Sanofi S.A. (France)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Abbott India Limited (India)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Aspen Holdings (South Africa)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Bristol-Myers Squibb Company (US)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Eisai Inc. (US)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Mitsubishi Tanabe Pharma Corporation (Japan)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Teva Pharmaceutical Industries Ltd. (Israel)

LIST OF FIGURES

Fig Global Dibigatran Market Size and CAGR 2013-2018 (Million USD)
Fig Global Dibigatran Market Size and CAGR 2013-2018 (Volume)
Fig Global Dibigatran Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global Dibigatran Market Forecast and CAGR 2019-2025 (Volume)
Fig stroke Market Size and CAGR 2013-2018 (Million USD)
Fig stroke Market Size and CAGR 2013-2018 (Volume)
Fig stroke Market Forecast and CAGR 2019-2025 (Million USD)
Fig stroke Market Forecast and CAGR 2019-2025 (Volume)
Fig deep vein thrombosis Market Size and CAGR 2013-2018 (Million USD)
Fig deep vein thrombosis Market Size and CAGR 2013-2018 (Volume)
Fig deep vein thrombosis Market Forecast and CAGR 2019-2025 (Million USD)
Fig deep vein thrombosis Market Forecast and CAGR 2019-2025 (Volume)
Fig pulmonary embolism Market Size and CAGR 2013-2018 (Million USD)
Fig pulmonary embolism Market Size and CAGR 2013-2018 (Volume)
Fig pulmonary embolism Market Forecast and CAGR 2019-2025 (Million USD)
Fig pulmonary embolism Market Forecast and CAGR 2019-2025 (Volume)
Fig systemic embolism Market Size and CAGR 2013-2018 (Million USD)
Fig systemic embolism Market Size and CAGR 2013-2018 (Volume)
Fig systemic embolism Market Forecast and CAGR 2019-2025 (Million USD)
Fig systemic embolism Market Forecast and CAGR 2019-2025 (Volume)
Fig Pradaxa Market Size and CAGR 2013-2018 (Million USD)
Fig Pradaxa Market Size and CAGR 2013-2018 (Volume)
Fig Pradaxa Market Forecast and CAGR 2019-2025 (Million USD)
Fig Pradaxa Market Forecast and CAGR 2019-2025 (Volume)
Fig Pradax Market Size and CAGR 2013-2018 (Million USD)
Fig Pradax Market Size and CAGR 2013-2018 (Volume)
Fig Pradax Market Forecast and CAGR 2019-2025 (Million USD)
Fig Pradax Market Forecast and CAGR 2019-2025 (Volume)
Fig Prazaxa Market Size and CAGR 2013-2018 (Million USD)
Fig Prazaxa Market Size and CAGR 2013-2018 (Volume)
Fig Prazaxa Market Forecast and CAGR 2019-2025 (Million USD)
Fig Prazaxa Market Forecast and CAGR 2019-2025 (Volume)


More Publications